Elevated LPS levels in individuals with obesity and T2D contribute to metabolic endotoxemia [9], which, in turn, downregulates intestinal tight junction proteins such as occludin and zonula occludens-1 [9], further compromising the epithelial barrier. The gene discussed is OCLN; the disease is obesity disorder.